Internet highs--seizures after consumption of synthetic cannabinoids purchased online.
Babak Tofighi, Joshua D Lee
Journal of Addiction Medicine September 2012 DOI: 10.1097/adm.0b013e3182619004 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A 48-year-old man who consumed an herbal blend containing synthetic cannabinoids |
| Key findings | A 48-year-old man lost consciousness and experienced several seizures after consuming an herbal blend, which the authors attribute to a large amount of synthetic cannabinoids. He recovered without neurological sequelae despite a complicated ICU stay, and the authors note that the lack of routine laboratory testing and treatment options delayed diagnosis and appropriate therapy. |
Abstract
Since 2004, a new wave of synthetic cannabinoids (SCs) known as "Spice drugs" has come under scrutiny because of their suspected link to neurological and psychiatric sequelae. These "herbal incense" or "potpourri blends" have gained popularity as a result of being more potent than natural cannabinoids, are not detected with current screening tests, and are easily modified by manufacturers to bypass legal restrictions. Unfortunately, cases of withdrawal phenomena, nausea, hypertension, and psychosis are now being reported in the medical literature. In addition, after reports in lay media of seizures and coma attributed to the consumption of the drug, anecdotal reports have emerged of similar findings in the medical literature. We report on a 48-year-old man who, after consuming the herbal blend, lost consciousness and suffered several episodes of seizures. Despite a complicated ICU stay, the patient recovered well with no subsequent neurological sequelae. The authors interpreted the history and findings consistent with the consumption of a large amount of synthetic cannabinoids leading to new-onset seizures and coma. However, at the time of admission, the lack of routine laboratory testing and treatment options delayed the diagnosis and delivery of appropriate therapy.
Citations in the library
Cited by 6
- Designer drugs: mechanism of action and adverse effects Archives of Toxicology April 1, 2020
- Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature Neuroscience & Biobehavioral Reviews October 19, 2025
- Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice. Behavioural Pharmacology December 2014
- Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence November 1, 2014
- Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats. Pharmacology, Biochemistry, and Behavior September 2014
and 1 more in the library